Authors:
GENDRAULT B
LETHOR JP
BOSSER G
MARCON F
BORDIGONI P
JONVEAUX P
LEHEUP B
Citation: B. Gendrault et al., AUTOIMMUNE HYPOTHYROIDISM IN 2 CASES OF THE VELOCARDIO-FACIAL SYNDROME - A NEW PIECE OF THE 22Q11 DELETION PUZZLE, European journal of human genetics, 6, 1998, pp. 1163-1163
Authors:
MICHON JM
HARTMANN O
BOUFFET E
MERESSE V
COZE C
RUBIE H
BORDIGONI P
CATTIAUX E
WARD N
BERNARD JL
LEMERLE J
ZUCKER JM
PHILIP T
Citation: Jm. Michon et al., AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE-2 STUDY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) AS AN ADJUNCT TO COMBINATION CHEMOTHERAPY IN PEDIATRIC-PATIENTS WITH METASTATIC NEUROBLASTOMA, European journal of cancer, 34(7), 1998, pp. 1063-1069
Authors:
TCHIRKOV A
KANOLD J
GIOLLANT M
HALLEHAUS P
BERGER M
RAPATEL C
LUTZ P
BERGERON C
PLANTAZ D
VANNIER JP
STEPHAN JL
FAVROT M
BORDIGONI P
MALET P
BRIANCON G
DEMEOCQ F
Citation: A. Tchirkov et al., MOLECULAR MONITORING OF TUMOR-CELL CONTAMINATION IN LEUKAPHERESIS PRODUCTS FROM STAGE-IV NEUROBLASTOMA PATIENTS BEFORE AND AFTER POSITIVE CD34 SELECTION, Medical and pediatric oncology, 30(4), 1998, pp. 228-232
Authors:
BORDIGONI P
ESPEROU H
SOUILLET G
PICO T
MICHEL G
LACOUR B
REIFFERS J
SADOUN A
ROHRLICH P
JOUET JP
MILPIED N
LUTZ P
PLOUVIER E
CORNU G
VANNIER JP
GANDEMER V
RUBIE H
GRATECOS N
LEVERGER G
STEPHAN JL
BOUTARD P
VERNANT JP
Citation: P. Bordigoni et al., TOTAL-BODY IRRADIATION-HIGH-DOSE CYTOSINE-ARABINOSIDE AND MELPHALAN FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION FROM HLA-IDENTICAL SIBLINGS IN THE TREATMENT OF CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIAAFTER RELAPSE WHILE RECEIVING CHEMOTHERAPY - A SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE STUDY, British Journal of Haematology, 102(3), 1998, pp. 656-665
Authors:
DONADIEU J
AUCLERC MF
BARUCHEL A
LEBLANC T
LANDMANPARKER J
PEREL Y
MICHEL G
CORNU G
BORDIGONI P
SOMMELET D
LEVERGER G
HILL C
SCHAISON G
Citation: J. Donadieu et al., CRITICAL-STUDY OF PROGNOSTIC FACTORS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - DIFFERENCES IN OUTCOME ARE POORLY EXPLAINED BY THE MOST SIGNIFICANT PROGNOSTIC VARIABLES, British Journal of Haematology, 102(3), 1998, pp. 729-739
Authors:
FEUGIER P
SCHUHMACHER A
GIRARD F
ALLA F
BENSOUSSAN D
LATGER V
WITZ F
CARRET AS
BORDIGONI P
JANOT C
Citation: P. Feugier et al., BONE-MARROW RECOVERY AFTER AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION - ROLE OF POSTTHAWING PARAMETERS, British Journal of Haematology, 102(1), 1998, pp. 68-68
Authors:
LEVERGER G
LEBLANC T
AUVRIGNON A
BARUCHEL A
DEFACHELLES AS
LAMAGNERE JP
BORDIGONI P
AUZANNEAU G
LANDMANPARKER J
MAHMOUD HH
Citation: G. Leverger et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CHILDREN WITH RECURRENT ACUTE NONLYMPHOCYTIC LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 223-223
Authors:
BENKERROU M
JAIS JP
LEBLOND V
DURANDY A
SUTTON L
BORDIGONI P
GARNIER JL
LEBIDOIS J
LEDEIST F
BLANCHE S
FISCHER A
Citation: M. Benkerrou et al., ANTI-B-CELL MONOCLONAL-ANTIBODY TREATMENT OF SEVERE POSTTRANSPLANT B-LYMPHOPROLIFERATIVE DISORDER - PROGNOSTIC FACTORS AND LONG-TERM OUTCOME, Blood, 92(9), 1998, pp. 3137-3147
Authors:
TIBERGHIEN P
CAHN JY
BRION A
DECONINCK E
RACADOT E
HERVE P
MILPIED N
LIOURE B
GLUCKMAN E
BORDIGONI P
JACOB W
CHIANG YW
MARCUS S
REYNOLDS C
LONGO D
Citation: P. Tiberghien et al., USE OF DONOR T-LYMPHOCYTES EXPRESSING HERPES-SIMPLEX THYMIDINE KINASEIN ALLOGENEIC BONE-MARROW TRANSPLANTATION - A PHASE I-II STUDY, Human gene therapy, 8(5), 1997, pp. 615-624
Authors:
CAVAZZANACALVO M
JABADO N
BORDIGONI P
MICHEL G
HADDAD E
MECHINAUD F
LANDMANPARKER J
LEBLANC T
PLOUVIER E
BARUCHEL A
STEPHAN JL
SOUILLET G
VILMER E
WIJDENES J
LEDEIST F
FISCHER A
Citation: M. Cavazzanacalvo et al., IN-VIVO INFUSION OF ANTI-LFA-1 AND ANTI-CD2 ANTIBODIES PREVENTS GRAFTFAILURE AFTER HLA PARTIALLY INCOMPATIBLE BONE-MARROW TRANSPLANTATION IN CHILDREN WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia & lymphoma, 28(1-2), 1997, pp. 103-112
Authors:
MAYNADIE M
CAMPOS L
MOSKOVTCHENKO P
SABIDO O
AHO S
LENORMAND B
CARLI PM
GUYOTAT D
BENE MC
FAURE G
CAPIOD JC
GARDAIS J
FEUILLARD J
RAPHAEL M
LACOMBE R
LECALVEZ G
LEGLISE MC
DENEYS V
MASSON AM
BERNIER M
MALET AM
SALAUN C
BOURIN P
RAPATEL C
TAVERNIER F
JOUAULT H
LELONG F
CHRETIEN P
SOLARY E
CASASNOVAS RO
MAYNADIE M
MOSKOVTCHENKO P
FAVRE M
BENSA JC
JACOB MC
WALLEF G
SARIAUX C
TRIMOREAU F
PRALORAN V
CAMPOS L
SABIDO O
VASSELON C
BRUNET C
PONCELET P
GUITARD AM
TAIB J
LAVABREBERTRAND T
JUNG G
KANDEL G
GARAND R
PHILIP P
SUDAKA I
MONPOUX F
VANHAEKE D
PERROT JY
MARIE JP
VALENSI F
VERGE V
HOMBERG JC
SCHAISON G
BOUMSELL L
DOUAY L
SAMSON T
BRIZARD A
DALIPHARD S
DRENOU B
LEES O
LENORMAND B
POILANE B
FALKENRODT A
ALBERT A
KUHLEIN E
ESTIENNE MH
BREMOND JL
DEGENNE M
LEBARON F
REUMAUX G
DUTHILLEUL P
BENE MC
FAURE G
BORDIGONI P
WITZ F
KOLLOPSARDA MN
BAYLE C
ANTONINI J
BOUCHEIX C
CHARPENTIER A
Citation: M. Maynadie et al., HETEROGENOUS EXPRESSION OF CD15 IN ACUTE LYMPHOBLASTIC-LEUKEMIA - A STUDY OF 10 ANTI-CD15 MONOCLONAL-ANTIBODIES IN 158 PATIENTS, Leukemia & lymphoma, 25(1-2), 1997, pp. 135-143
Authors:
COZE C
HARTMANN O
MICHON J
FRAPPAZ D
DUSOL F
RUBIE H
PLOUVIER E
LEVERGER G
BORDIGONI P
BEHAR C
BECK D
MECHINAUD F
BERGERON C
PLANTAZ D
OTTEN J
ZUCKER JM
PHILIP T
BERNARD JL
Citation: C. Coze et al., NB87 INDUCTION PROTOCOL FOR STAGE-4 NEUROBLASTOMA IN CHILDREN OVER 1 YEAR OF AGE - A REPORT FROM THE FRENCH-SOCIETY-OF-PEDIATRIC-ONCOLOGY, Journal of clinical oncology, 15(12), 1997, pp. 3433-3440
Authors:
CHASTAGNER P
MOUGEL L
LOZNIEWSKI A
SCHMITT C
CARRET AS
BORDIGONI P
WEBER M
SOMMELET D
Citation: P. Chastagner et al., EFFICACY OF TICARCILLIN-CLAVULANATE AND N ETILMICIN COMBINATION, IN THE TREATMENT OF PYREXIA IN NEUTROPENIC CHILDREN, Medecine et maladies infectieuses, 27(3), 1997, pp. 301-305
Authors:
DECONINCK E
CAHN JY
MILPIED N
JOUET JP
VERNANT JP
ESPEROU H
LIOURE B
BORDIGONI P
LEBLOND V
TROUSSARD X
CAILLOT D
CORDONNIER JM
HERVE P
Citation: E. Deconinck et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST REMISSION - LONG-TERM RESULTS FOR 42 PATIENTS CONDITIONED WITH AN INTENSIFIED REGIMEN (TBI, HIGH-DOSE ARA-C AND MELPHALAN), Bone marrow transplantation, 20(9), 1997, pp. 731-735
Authors:
JOURDAN E
MARANINCHI D
REIFFERS J
GLUCKMAN E
RIO B
JOUET JP
MICHALLET M
MOLINA L
ARCHIMBAUD E
HAROUSSEAU JL
IFRAH N
ATTAL M
GUILHOT F
KUENTZ M
GUYOTAT D
PICO JL
DAURIAC C
LEGROS M
DREYFUS F
BORDIGONI P
LEBLOND V
GRATECOS N
VARET B
AUZANNEAU C
TILLY H
VILMER E
BARDOU VJ
BLAISE D
Citation: E. Jourdan et al., EARLY ALLOGENEIC TRANSPLANTATION FAVORABLY INFLUENCES THE OUTCOME OF ADULT PATIENTS SUFFERING FROM ACUTE MYELOID-LEUKEMIA, Bone marrow transplantation, 19(9), 1997, pp. 875-881
Authors:
MARIE B
ANTUNES L
BAYLAC F
GREMILLET S
PIALOUX A
GUERCI A
BORDIGONI P
PLENAT F
VIGNAUD JM
Citation: B. Marie et al., PRINS METHOD - UTILIZATION FOR DETECTION OF HOST-CELLS FOLLOWING SEX-MISMATCHED BONE-MARROW TRANSPLANTATION, Annales de pathologie, 17(1), 1997, pp. 11-16
Authors:
LEVY J
ESPANOLBOREN T
THOMAS C
FISCHER A
TOVO P
BORDIGONI P
RESNICK I
FASTH A
BAER M
GOMEZ L
SANDERS EAM
TABONE MD
PLANTAZ D
ETZIONI A
MONAFO V
ABINUN M
HAMMARSTROM L
ABRAHAMSEN T
JONES A
FINN A
KLEMOLA T
DEVRIES E
SANAL O
PEITSCH MC
NOTARANGELO LD
Citation: J. Levy et al., CLINICAL SPECTRUM OF X-LINKED HYPER-IGM SYNDROME, The Journal of pediatrics, 131(1), 1997, pp. 47-54
Authors:
DONADIEU J
AUCLERC MF
BARUCHEL A
LEBLANC T
LANDMANPARKER J
PEREL Y
MICHEL G
CORNU G
BORDIGONI P
HILL C
SOMMELET D
LEVERGER G
SCHAISON G
Citation: J. Donadieu et al., BOW THE MOST SIGNIFICANT PROGNOSTIC VARIABLES IN CHILDHOOD ALL CONTRIBUTED TO EXPLAINED OUTCOME, Blood, 90(10), 1997, pp. 3686-3686
Authors:
CARRET AS
VISANICA S
BRIQUEL E
SOMMELET D
BORDIGONI P
Citation: As. Carret et al., RECOMBINANT HUMAN TISSUE-PLASMINOGEN ACTIVATOR (T-PA) FOR THE TREATMENT OF SEVERE HEPATIC VENOOCCLUSIVE DISEASE (VOD) IN PEDIATRIC BONE-MARROW TRANSPLANT (BMT) PATIENTS, Blood, 90(10), 1997, pp. 967-967
Authors:
MICHEL G
BARUCHEL A
TABONE MD
NELKEN B
LEBLANC T
THURET I
BORDIGONI P
BERGERON C
ESPEROUBOURDEAU H
PEREL Y
VANNIER JP
DELUMLEY L
DOMMERGUES JP
LAMAGNERE JP
COUILLAUD G
AUVRIGNON A
SCHAISON G
LEVERGER G
Citation: G. Michel et al., INDUCTION CHEMOTHERAPY FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION OR AGGRESSIVE CONSOLIDATION CHEMOTHERAPY IN CHILDHOOD ACUTE MYELOBLASTIC-LEUKEMIA - A PROSPECTIVE-STUDY FROM THE NCH-SOCIETY-OF-PEDIATRIC-HEMATOLOGY-AND-IMMUNOLOGY (SHIP), HEM CELL TH, 38(2), 1996, pp. 169-176
Authors:
DINI G
RONDELLI R
MIANO M
VOSSEN J
GLUCKMAN E
PETERS C
BORDIGONI P
LOCATELLI F
MINIERO R
LJUNGMAN P
SAARINEN U
KLINGEBIEL T
ORTEGA J
LANINO E
Citation: G. Dini et al., UNRELATED-DONOR BONE-MARROW TRANSPLANTATION FOR PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA IN CHILDREN - EXPERIENCE OF 8EUROPEAN COUNTRIES, Bone marrow transplantation, 18, 1996, pp. 80-85
Authors:
MICHEL G
LEVERGER G
LEBLANC T
NELKEN B
BARUCHEL A
LANDMANPARKER J
THURET I
BERGERON C
BORDIGONI P
ESPEROUBOURDEAU H
PEREL Y
VANNIER JP
SCHAISON G
Citation: G. Michel et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION VS AGGRESSIVE POSTREMISSION CHEMOTHERAPY FOR CHILDREN WITH ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION - A PROSPECTIVE-STUDY FROM THE NCH-SOCIETY-OF-PEDIATRIC-HEMATOLOGY-AND-IMMUNOLOGY (SHIP), Bone marrow transplantation, 17(2), 1996, pp. 191-196
Authors:
CASANOVA JL
BLANCHE S
EMILE JF
JOUANGUY E
LAMHAMEDI S
ALTARE F
STEPHAN JL
BERNAUDIN F
BORDIGONI P
TURCK D
LACHAUX A
BERTINI M
BOURRILLON A
DOMMERGUES JP
POCIDALO MA
LEDEIST F
GAILLARD JL
GRISCELLI C
FISCHER A
Citation: Jl. Casanova et al., IDIOPATHIC DISSEMINATED BACILLUS-CALMETTE-GUERIN INFECTION - A FRENCHNATIONAL RETROSPECTIVE STUDY, Pediatrics, 98(4), 1996, pp. 774-778
Authors:
CAVAZZANACALVO M
BORDIGONI P
MICHEL G
ESPEROU H
SOUILLET G
LEBLANC T
STEPHAN JL
VANNIER JP
MECHINAUD F
REIFFERS J
VILMER E
LANDMANPARKER J
BENKERROU M
BARUCHEL A
PICO J
BERNAUDIN F
BERGERON C
PLOUVIER E
THOMAS C
WIJDENES J
LACOUR B
BLANCHE S
FISCHER A
Citation: M. Cavazzanacalvo et al., A PHASE-II TRIAL OF PARTIALLY INCOMPATIBLE BONE-MARROW TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN - PREVENTION OF GRAFT-REJECTION WITH ANTI-LFA-1 AND ANTI-CD2 ANTIBODIES, British Journal of Haematology, 93(1), 1996, pp. 131-138